Sphere Medical Gears Up For EU Expansion With Proxima 4
Sphere Medical is looking to increase penetration of the European market with the launch of its next-generation blood sampling device Proxima 4, which was CE-marked in September. The company said it aims to "shake up" the frequent blood measurement market.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
The UK government has ordered 3.5 million home test kits to identify people who have antibodies to the SARS-CoV-2 virus. However, it has not said who will supply the test kits.
Thermo Fisher has priced an offering of $2.2bn senior notes to pay for its planned acquisition of Qiagen. The news comes the same week, Qiagen confirmed Thierry Bernard as permanent CEO following the departure of former leader Peer Schatz.